Trial Profile
An open-label, multicenter, therapeutic effect and safety study of lenalidomide plus indexamethasone in refractory/relapsed MM
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Apr 2016 New trial record